Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

Share Price is delayed by 15 minutes
Get Live Data
4,678.00    42.00 (0.91%)
Bid:
4,676.00
Ask:
4,682.00
Spread: 6.00 (0.128%)
Market Cap: £1.44b
CKN Live PriceLast checked at - London Stock Exchange

Intraday Clarkson Share Chart

Completion of Placing

17 Mar 2016 07:00

RNS Number : 3682S
Clarkson PLC
17 March 2016
 

This announcement and the information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from Australia, Canada, Japan, the republic of South Africa, the United States or any other jurisdiction in which the same would be unlawful. Please see the important notice at the end of this announcement.

 

17 March 2016

 

Clarkson PLC

 

COMPLETION OF PLACING OF SHARES IN CLARKSON PLC ("CLARKSONS" OR "THE COMPANY") AND NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

 

 

Clarksons announces that it has received notification that on 17 March 2016 a number of former shareholders of RS Platou ASA ("Platou") sold 2,034,416 ordinary shares in the capital of the Company in London at a price of 1840p per ordinary share pursuant to the secondary placing announced on 16 March 2016.

Peter M. Anker, a PDMR of the Company, has sold 169,000 Placing Shares as part of the Placing. Post transaction, Peter M. Anker holds 357,477 existing ordinary shares and 2,667 conditional awards in the capital of the company, equivalent to 1.2 per cent. of issued ordinary share capital.

This notification is made in order to satisfy Disclosure Rule and Transparency Rule 3.1.4R.

 

 For further information contact:

Clarkson PLC

+44 207 334 0000

 

 

Andi Case

 

Jeff Woyda

 

 

 

 

 

Panmure Gordon (UK) Limited

+44 207 886 2500

 

 

Richard Gray

 

Andrew Potts

 

Tom Salvesen

 

 

 

 

 

Nomura International plc

+44 207 102 1000

 

 

Andrew McNaught

 

Nicholas Marren

Simon Aird

 

 

 

 

Hudson Sandler

 

+44 207 796 4133

 

Michael Sandler

Katie Matthews

 

 

IMPORTANT NOTICE

 

The distribution of this announcement and the offer and sale of the Placing Shares in certain jurisdictions may be restricted by law. The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by Clarksons, Nomura, Panmure Gordon or any of their respective affiliates that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

 

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and dependencies, any State of the United States and the District of Columbia), Australia, Canada, Japan or Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

 

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement is directed exclusively at persons who are 'qualified investors' within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression 'Prospectus Directive' means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression '2010 PD Amending Directive' means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated.

 

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

 

Panmure Gordon is authorised and regulated by the Financial Conduct Authority in the United Kingdom, and is acting exclusively for the Company and the selling shareholders and for no one else in connection with the Placing and will not regard any other person as a client in relation to the Placing and will not be responsible to any other person for providing the protections afforded to its clients nor for providing advice in relation to the Placing or any other matter referred to in this announcement.

 

Nomura is authorised by the Prudential Regulation Authority and is regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, and is acting as Placing Agent to Panmure Gordon in respect of the Placing, and will not be responsible to any other person for providing the protections afforded to clients nor for providing advice in relation to the Placing or any other matter referred to in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFIEDMFMSEED
Date   Source Headline
1st Jun 202612:00 pmRNSTotal Voting Rights
15th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20264:30 pmRNSDirector/PDMR Shareholding
7th May 20264:45 pmRNSResult of AGM
7th May 202612:00 pmRNSTrading Statement
1st May 202612:00 pmRNSTotal Voting Rights
27th Apr 20263:00 pmRNSBlock Listing Interim Review
27th Apr 202612:00 pmRNSHolding(s) in Company
23rd Apr 20265:00 pmRNSHolding(s) in Company
21st Apr 20265:00 pmRNSDirector/PDMR Shareholding
1st Apr 20263:30 pmRNSTotal Voting Rights
30th Mar 20265:55 pmRNSAnnual Report and Notice of AGM
19th Mar 20263:00 pmRNSDirector/PDMR Shareholding
18th Mar 20261:21 pmRNSAcquisition of the Link Group
9th Mar 20267:00 amRNSPreliminary results
4th Mar 20263:30 pmRNSHolding(s) in Company
2nd Feb 202612:00 pmRNSTotal Voting Rights
9th Jan 20267:00 amRNSTrading Statement
8th Jan 202612:41 pmRNSAcquisition of Zuma Labs Limited
2nd Jan 202612:00 pmRNSTotal Voting Rights
1st Dec 202512:00 pmRNSTotal Voting Rights
3rd Nov 202512:00 pmRNSTotal Voting Rights
27th Oct 202512:00 pmRNSBlock listing Interim Review
24th Oct 20259:00 amRNSAdditional Listing
21st Oct 20253:30 pmRNSDirector/PDMR Shareholding
2nd Oct 202512:00 pmRNSCompany Secretary Change
16th Sep 20257:00 amRNSRetirement of Director
1st Sep 202511:00 amRNSTotal Voting Rights
4th Aug 20257:00 amRNSInterim results
1st Jul 202512:00 pmRNSTotal Voting Rights
2nd Jun 202511:00 amRNSTotal Voting Rights
21st May 20254:30 pmRNSDirector/PDMR Shareholding
2nd May 202511:30 amRNSDirector/PDMR Shareholding
1st May 20256:00 pmRNSResult of AGM
1st May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 202512:27 pmRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Statement
28th Apr 20256:00 pmRNSBlock listing Interim Review
23rd Apr 20255:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20255:00 pmRNSDirector/PDMR Shareholding
1st Apr 20252:30 pmRNSTotal Voting Rights
25th Mar 20255:15 pmRNSAnnual Financial Report
13th Mar 20253:00 pmRNSHolding(s) in Company
12th Mar 20252:00 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSPreliminary results
3rd Feb 202512:30 pmRNSTotal Voting Rights
31st Jan 20255:00 pmRNSHolding(s) in Company
13th Jan 20254:30 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.